Bavarian Nordic delivers strategic smallpox vaccine to US
This article was originally published in Scrip
Executive Summary
Danish biotech company Bavarian Nordic has delivered the first batch of one million doses of its smallpox vaccine Imvamune to be stored in the US Strategic National Stockpile as a resource for fighting bioterrorism. The FDA authorised the delivery, which was the company's first major product sale in the US, on 17 March.